Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
NCT02769546 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-04-02
Summary
The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice services. Overall, the project will pinpoint opportunities for better patient physician communication regarding prognosis and end-of-life care and allow for more informed and tailored decision-making.
Conditions
Interventions
- OTHER
-
Surveys
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Principal Investigators
-
Ashley Haggerty, MD · Abramson Cancer Center at Penn Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2018-01-31
- Completion
- 2018-01-31
Countries
- United States
Study Locations
More Related Trials
-
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT01372787 ·Status: UNKNOWN
-
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer
NCT02973750 ·Status: COMPLETED
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265 ·Status: COMPLETED
-
Sexual Functioning After Primary Treatment of Ovarian Cancer
NCT00596544 ·Status: TERMINATED
-
Neoadjuvant Therapy for Ovarian Cancer
NCT01146795 ·Status: COMPLETED ·Phase: PHASE2
-
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538 ·Status: COMPLETED ·Phase: PHASE2
-
New Biomarkers Evaluating Ovarian Cancer
NCT01466049 ·Status: COMPLETED
-
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
NCT05047926 ·Status: COMPLETED ·Phase: NA
-
Nudge to Gynecologic Oncology
NCT06451263 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
NCT01366183 ·Status: UNKNOWN
-
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
NCT00525460 ·Status: COMPLETED
-
Women Surviving Ovarian Cancer
NCT00596349 ·Status: COMPLETED
-
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
NCT01468909 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer
NCT02406235 ·Status: COMPLETED
-
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
NCT04204811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology
NCT07078409 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
NCT00191646 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
NCT02125513 ·Status: UNKNOWN ·Phase: PHASE2
-
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
NCT01626014 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
NCT01080521 ·Status: COMPLETED